Management of Heart Failure with Renal Artery Ischemia

Fonarow, 2007, Temporal trends in clinical characteristics, treatments, and outcomes for heart failure hospitalizations, 2002 to 2004: findings from Acute Decompensated Heart Failure National Registry (ADHERE), Am Heart J, 153, 1021, 10.1016/j.ahj.2007.03.012 Chae, 2003, Mild renal insufficiency and risk of congestive heart failure in men and women > or = 70 years of age, Am J Cardiol, 92, 682, 10.1016/S0002-9149(03)00822-1 Smith, 2006, Renal impairment and outcomes in heart failure: systematic review and meta-analysis, J Am Coll Cardiol, 47, 1987, 10.1016/j.jacc.2005.11.084 Gottlieb, 2002, The prognostic importance of different definitions of worsening renal function in congestive heart failure, J Card Fail, 8, 136, 10.1054/jcaf.2002.125289 Shlipak, 2005, Cystatin-C and mortality in elderly persons with heart failure, J Am Coll Cardiol, 45, 268, 10.1016/j.jacc.2004.09.061 Levin, 1999, Left ventricular mass index increase in early renal disease: impact of decline in hemoglobin, Am J Kidney Dis, 34, 125, 10.1016/S0272-6386(99)70118-6 Weiner, 2005, Effects of anemia and left ventricular hypertrophy on cardiovascular disease in patients with chronic kidney disease, J Am Soc Nephrol, 16, 1803, 10.1681/ASN.2004070597 Foley, 1996, Impact of hypertension on cardiomyopathy, morbidity and mortality in end-stage renal disease, Kidney Int, 49, 1379, 10.1038/ki.1996.194 Martins, 2007, Prevalence of cardiovascular risk factors and the serum levels of 25-hydroxyvitamin D in the United States: data from the Third National Health and Nutrition Examination Survey, Arch Intern Med, 167, 1159, 10.1001/archinte.167.11.1159 Schleithoff, 2006, Vitamin D supplementation improves cytokine profiles in patients with congestive heart failure: a double-blind, randomized, placebo-controlled trial, Am J Clin Nutr, 83, 754, 10.1093/ajcn/83.4.754 Park, 1999, Intravenous calcitriol regresses myocardial hypertrophy in hemodialysis patients with secondary hyperparathyroidism, AJKD, 33, 73, 10.1016/S0272-6386(99)70260-X Zittermann, 2006, Vitamin D insufficiency in congestive heart failure: why and what to do about it?, Heart Fail Rev, 11, 25, 10.1007/s10741-006-9190-8 National Institutes of Health. The effect of calcium and vitamin D in patients with heart failure [clinical trial]. Available at: http://www.clinicaltrials.gov/ct2/show/NCT00497900. Accessed August 6, 2008. Guo, 2007, Atherosclerotic renovascular disease in older US patients starting dialysis, 1996 to 2001, Circulation, 115, 50, 10.1161/CIRCULATIONAHA.106.637751 Textor, 2004, Ischemic nephropathy: where are we now?, J Am Soc Nephrol, 15, 1974, 10.1097/01.ASN.0000133699.97353.24 Alcazar, 2000, Ischemic nephropathy: clinical characteristics and treatment, Am J Kidney Dis, 36, 883, 10.1053/ajkd.2000.19077 Cheung, 2005, Dilemmas in the management of renal artery stenosis, Br Med Bull, 73–74, 35, 10.1093/bmb/ldh049 Safian, 2001, Renal-artery stenosis, N Engl J Med, 344, 431, 10.1056/NEJM200102083440607 Pascual, 2005, Renal fibromuscular dysplasia in elderly persons, Am J Kidney Dis, 45, e63, 10.1053/j.ajkd.2005.01.039 Harding, 1992, Renal artery stenosis: prevalence and associated risk factors in patients undergoing routine cardiac catheterization, J Am Soc Nephrol, 2, 1608, 10.1681/ASN.V2111608 Labropoulos, 2007, Renovascular disease among patients referred for renal duplex ultrasonography, J Vasc Surg, 46, 731, 10.1016/j.jvs.2007.05.058 Kalra, 2005, Atherosclerotic renovascular disease in United States patients aged 67 years or older: risk factors, revascularization, and prognosis, Kidney Int, 68, 293, 10.1111/j.1523-1755.2005.00406.x Dorros, 2002, Multicenter Palmaz stent renal artery stenosis revascularization registry report: four-year follow-up of 1,058 successful patients, Catheter Cardiovasc Interv, 55, 182, 10.1002/ccd.3050 Buller, 2004, The profile of cardiac patients with renal artery stenosis, J Am Coll Cardiol, 43, 1606, 10.1016/j.jacc.2003.11.050 Hansen, 2002, Prevalence of renovascular disease in the elderly: a population-based study, J Vasc Surg, 36, 443, 10.1067/mva.2002.127351 Plouin, 2007, Fibromuscular dysplasia, Orphanet J Rare Dis, 2 Kincaid, 1968, Fibromuscular dysplasia of the renal arteries. Arteriographic features, classification, and observations on natural history of the disease, Am J Roentgenol Radium Ther Nucl Med, 104, 271, 10.2214/ajr.104.2.271 Lassiter, 1998, The string-of-beads sign, Radiology, 206, 437, 10.1148/radiology.206.2.9457197 Bofinger, 1999, Increased severity of multifocal renal arterial fibromuscular dysplasia in smokers, J Hum Hypertens, 13, 517, 10.1038/sj.jhh.1000873 Sang, 1989, Etiologic factors in renovascular fibromuscular dysplasia. A case-control study, Hypertension, 14, 472, 10.1161/01.HYP.14.5.472 Maher, 1988, Captopril-enhanced 99mTc DTPA scintigraphy in the detection of renal-artery stenosis, Nephrol Dial Transplant, 3, 608, 10.1093/oxfordjournals.ndt.a091714 Ludwig, 2003, Calcium channel blockers: a potential cause of false-positive captopril renography, Clin Nucl Med, 28, 108, 10.1097/01.RLU.0000048679.45832.F3 Olbricht, 1995, Minimally invasive diagnosis of renal artery stenosis by spiral computed tomography angiography, Kidney Int, 48, 1332, 10.1038/ki.1995.418 Leung, 1999, Magnetic resonance angiography versus duplex sonography for diagnosing renovascular disease, Hypertension, 33, 726, 10.1161/01.HYP.33.2.726 Barrett, 2006, Clinical practice. Preventing nephropathy induced by contrast medium, N Engl J Med, 354, 379, 10.1056/NEJMcp050801 McCullough, 2006, Risk prediction of contrast-induced nephropathy, Am J Cardiol, 98, 27K, 10.1016/j.amjcard.2006.01.022 Food and Drug Administration. FDA public health advisory: gadolinium-containing contrast agents for magnetic resonance imaging (MRI). Available at: http://www.fda.gov/cder/drug/advisory/gadolinium_agents_20061222.htm. Accessed August 6, 2008. Perazella, 2007, Gadolinium-induced nephrogenic systemic fibrosis in patients with kidney disease, Am J Med, 120, 561, 10.1016/j.amjmed.2007.01.032 Williams, 2007, Comparative accuracy of renal duplex sonographic parameters in the diagnosis of renal artery stenosis: paired and unpaired analysis, AJR Am J Roentgenol, 188, 798, 10.2214/AJR.06.0355 Radermacher, 2001, Use of Doppler ultrasonography to predict the outcome of therapy for renal-artery stenosis, N Engl J Med, 344, 410, 10.1056/NEJM200102083440603 Imanishi, 1980, Effects of prostaglandin I2 and E2 on renal hemodynamics and function and renin release, Jpn Circ J, 44, 875, 10.1253/jcj.44.875 Goldblatt, 1934, Studies on experimental hypertension I: the production of persistent elevation of systolic blood pressure by means of renal artery ischemia, J Exp Med, 59, 347, 10.1084/jem.59.3.347 Rundback, 2002, Chronic renal ischemia: pathophysiologic mechanisms of cardiovascular and renal disease, J Vasc Interv Radiol, 13, 1085, 10.1016/S1051-0443(07)61948-4 Maschio, 1996, Effect of the angiotensin-converting-enzyme inhibitor benazepril on the progression of chronic renal insufficiency. The Angiotensin-Converting-Enzyme Inhibition in Progressive Renal Insufficiency Study Group, N Engl J Med, 334, 939, 10.1056/NEJM199604113341502 Laviades, 2000, Transforming growth factor beta in hypertensives with cardiorenal damage, Hypertension, 36, 517, 10.1161/01.HYP.36.4.517 Hillege, 2000, Renal function, neurohormonal activation, and survival in patients with chronic heart failure, Circulation, 102, 203, 10.1161/01.CIR.102.2.203 Shokei, 2000, Molecular and cellular mechanisms in angiotensin II-mediated cardiovascular and renal disease, Pharmacol Rev, 52, 11 Minuz, 2002, Increased oxidative stress and platelet activation in patients with hypertension and renovascular disease, Circulation, 106, 2800, 10.1161/01.CIR.0000039528.49161.E9 Ikeda, 1995, Aldosterone inhibits nitric oxide synthesis in rat vascular smooth muscle cells induced by interleukin-1 beta, Eur J Pharmacol, 290, 69 Bloch, 1999, Prevention of recurrent pulmonary edema in patients with bilateral renovascular disease through renal artery stent placement, Am J Hypertens, 12, 1, 10.1016/S0895-7061(98)00201-5 Gandhi, 2001, The pathogenesis of acute pulmonary edema associated with hypertension, N Engl J Med, 344, 17, 10.1056/NEJM200101043440103 Pickering, 1988, Recurrent pulmonary oedema in hypertension due to bilateral renal artery stenosis: treatment by angioplasty or surgical revascularisation, Lancet, 2, 551, 10.1016/S0140-6736(88)92668-2 Missouris, 2000, “Apparent” heart failure: a syndrome caused by renal artery stenoses, Heart, 83, 152, 10.1136/heart.83.2.152 Hirsch, 2006, Circulation, 113, 1474, 10.1161/CIRCULATIONAHA.106.173994 2004, K/DOQI clinical practice guidelines on hypertension and antihypertensive agents in chronic kidney disease, Am J Kidney Dis, 43, S1 Tullis, 1999, Blood pressure, antihypertensive medication, and atherosclerotic renal artery stenosis, Am J Kidney Dis, 33, 675, 10.1016/S0272-6386(99)70218-0 Losito, 2005, Long-term follow-up of atherosclerotic renovascular disease. Beneficial effect of ACE inhibition, Nephrol Dial Transplant, 20, 1604, 10.1093/ndt/gfh865 van d, 1998, Angiotensin converting enzyme inhibitor-induced renal dysfunction in atherosclerotic renovascular disease, Kidney Int, 53, 986, 10.1111/j.1523-1755.1998.00840.x Hricik, 1990, Angiotensin-converting enzyme inhibitor-induced renal failure: causes, consequences, and diagnostic uses, J Am Soc Nephrol, 1, 845, 10.1681/ASN.V16845 Caps, 1998, Risk of atrophy in kidneys with atherosclerotic renal artery stenosis, Kidney Int, 53, 735, 10.1046/j.1523-1755.1998.00805.x Tegtmeyer, 1991, Results and complications of angioplasty in fibromuscular disease, Circulation, 83, I155 Davidson, 1996, Predictors of cure of hypertension in fibromuscular renovascular disease, Am J Kidney Dis, 28, 334, 10.1016/S0272-6386(96)90489-8 Gray, 2002, Clinical benefit of renal artery angioplasty with stenting for the control of recurrent and refractory congestive heart failure, Vasc Med, 7, 275, 10.1191/1358863x02vm456oa van Jaarsveld, 2000, The effect of balloon angioplasty on hypertension in atherosclerotic renal-artery stenosis. Dutch Renal Artery Stenosis Intervention Cooperative Study Group, N Engl J Med, 342, 1007, 10.1056/NEJM200004063421403 Marone, 2004, Preservation of renal function with surgical revascularization in patients with atherosclerotic renovascular disease, J Vasc Surg, 39, 322, 10.1016/j.jvs.2003.10.023